Previously, we proposed a rare autosomal recessive inherited enteropathy characterized by persistent blood and protein loss from the small intestine as chronic nonspecific multiple ulcers of the small intestine (CNSU). By whole-exome sequencing in five Japanese patients with CNSU and one unaffected individual, we found four candidate mutations in the SLCO2A1 gene, encoding a prostaglandin transporter. The pathogenicity of the mutations was supported by segregation analysis and genotyping data in controls. By Sanger sequencing of the coding regions, 11 of 12 other CNSU patients and 2 of 603 patients with a diagnosis of Crohn’s disease were found to have homozygous or compound heterozygous SLCO2A1 mutations. In total, we identified recessive SLCO2A1 mutations located at seven sites. Using RT-PCR, we demonstrated that the identified splice-site mutations altered the RNA splicing, and introduced a premature stop codon. Tracer prostaglandin E2 uptake analysis showed that the mutant SLCO2A1 protein for each mutation exhibited impaired prostaglandin transport. Immunohistochemistry and immunofluorescence analyses revealed that SLCO2A1 protein was expressed on the cellular membrane of vascular endothelial cells in the small intestinal mucosa in control subjects, but was not detected in affected individuals. These findings indicate that loss-of-function mutations in the SLCO2A1 gene encoding a prostaglandin transporter cause the hereditary enteropathy CNSU. We suggest a more appropriate nomenclature of “chronic enteropathy associated with SLCO2A1 gene” (CEAS).
References
[1]
Iddan G, Meron G, Glukhovsky A, Swain P (2000) Wireless capsule endoscopy. Nature 405: 417. doi: 10.1038/35013140
[2]
Yamamoto H, Sekine Y, Sato Y, Higashizawa T, Miyata T, et al. (2001) Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc 53: 216–220. pmid:11174299 doi: 10.1067/mge.2001.112181
[3]
Okabe H, Sakimura M (1968) Nonspecific multiple ulcer of the small intestine. Stomach and Intestine 3: 1539–1549.
[4]
Matsumoto T, Iida M, Matsui T, Yao T (2007) Chronic nonspecific multiple ulcers of the small intestine: a proposal of the entity from Japanese gastroenterologists to Western enteroscopists. Gastrointest Endosc 66: S99–107. pmid:17709045 doi: 10.1016/j.gie.2007.01.004
[5]
Bjarnason I, Hayllar J, MacPherson AJ, Russell AS (1993) Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832–1847. pmid:8500743
[6]
Matsumoto T, Iida M, Matsui T, Yao T, Watanabe H, et al. (2004) Non-specific multiple ulcers of the small intestine unrelated to non-steroidal anti-inflammatory drugs. J Clin Pathol 57: 1145–1150. pmid:15509673 doi: 10.1136/jcp.2003.015735
[7]
Matsumoto T, Nakamura S, Esaki M, Yada S, Koga H, et al. (2006) Endoscopic features of chronic nonspecific multiple ulcers of the small intestine: comparison with nonsteroidal anti-inflammatory drug-induced enteropathy. Dig Dis Sci 51: 1357–1363. pmid:16868823 doi: 10.1007/s10620-006-9080-x
[8]
Matsumoto T, Kubokura N, Matsui T, Iida M, Yao T (2011) Chronic nonspecific multiple ulcer of the small intestine segregates in offspring from consanguinity. J Crohns Colitis 5: 559–565. doi: 10.1016/j.crohns.2011.05.008. pmid:22115375
[9]
Asano K, Matsushita T, Umeno J, Hosono N, Takahashi A, et al. (2009) A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet 41: 1325–1329. doi: 10.1038/ng.482. pmid:19915573
[10]
Hirano A, Yamazaki K, Umeno J, Ashikawa K, Aoki M, et al. (2013) Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis 19: 526–533. doi: 10.1097/MIB.0b013e31828075e7. pmid:23388546
[11]
Zhang Z, Xia W, He J, Ke Y, Yue H, et al. (2012) Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet 90: 125–132. doi: 10.1016/j.ajhg.2011.11.019. pmid:22197487
[12]
Busch J, Frank V, Bachmann N, Otsuka A, Oji V, et al. (2012) Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing. J Invest Dermatol 132: 2473–2476. doi: 10.1038/jid.2012.146. pmid:22696055
[13]
Diggle CP, Parry DA, Logan CV, Laissue P, Rivera C, et al. (2012) Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat 33: 1175–1181. doi: 10.1002/humu.22111. pmid:22553128
[14]
Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, et al. (1995) Identification and characterization of a prostaglandin transporter. Science 268: 866–869. pmid:7754369 doi: 10.1126/science.7754369
[15]
Lu R, Kanai N, Bao Y, Schuster VL (1996) Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest 98: 1142–1149. pmid:8787677 doi: 10.1172/jci118897
[16]
Schuster VL (1998) Molecular mechanisms of prostaglandin transport. Annual Review of Physiology 60: 221–242. pmid:9558462 doi: 10.1146/annurev.physiol.60.1.221
[17]
Zhang Z, He JW, Fu WZ, Zhang CQ, Zhang ZL (2013) Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization. J Clin Endocrinol Metab 98: E923–933. doi: 10.1210/jc.2012-3568. pmid:23509104
[18]
Niizeki H, Shiohama A, Sasaki T, Seki A, Kabashima K, et al. (2013) The novel SLCO2A1 heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype. Br J Dermatol. doi: 10.1111/bjd.12790
[19]
Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, et al. (2008) Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 40: 789–793. doi: 10.1038/ng.153. pmid:18500342
[20]
Nomura T, Lu R, Pucci ML, Schuster VL (2004) The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol 65: 973–978. pmid:15044627 doi: 10.1124/mol.65.4.973
[21]
Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K (2002) 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Digestive Diseases and Sciences 47: 894–904. pmid:11991626 doi: 10.1016/s0016-5085(00)84899-4
[22]
Rao R, Redha R, Macias-Perez I, Su Y, Hao C, et al. (2007) Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. Journal of Biological Chemistry 282: 16959–16968. pmid:17401137 doi: 10.1074/jbc.m701214200
[23]
Takeuchi K, Kato S, Amagase K (2010) Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J Pharmacol Sci 114: 248–261. pmid:21041985 doi: 10.1254/jphs.10r06cr
[24]
Shoesmith JH, Tate GT, Wright CJ (1964) Multiple Strictures of the Jejunum. Gut 5: 132–135. pmid:14159400 doi: 10.1136/gut.5.2.132
[25]
Perlemuter G, Chaussade S, Soubrane O, Degoy A, Louvel A, et al. (1996) Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency. Gastroenterology 110: 1628–1632. pmid:8613071 doi: 10.1053/gast.1996.v110.pm8613071
[26]
Perlemuter G, Guillevin L, Legman P, Weiss L, Couturier D, et al. (2001) Cryptogenetic multifocal ulcerous stenosing enteritis: an atypical type of vasculitis or a disease mimicking vasculitis. Gut 48: 333–338. pmid:11171822 doi: 10.1136/gut.48.3.333
[27]
Brooke MA, Longhurst HJ, Plagnol V, Kirkby NS, Mitchell JA, et al. (2014) Cryptogenic multifocal ulcerating stenosing enteritis associated with homozygous deletion mutations in cytosolic phospholipase A2-alpha. Gut 63: 96–104. doi: 10.1136/gutjnl-2012-303581. pmid:23268370
[28]
Adler DH, Cogan JD, Phillips JA 3rd, Schnetz-Boutaud N, Milne GL, et al. (2008) Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J Clin Invest 118: 2121–2131. doi: 10.1172/JCI30473. pmid:18451993
[29]
Yao T, Iida M, Matsumoto T (2004) Chronic hemorrhagic ulcers of the small intestine or chronic nonspecific multiple ulcers of the small intestine. In: T Y, M I, editors. Diseases of the small intestine. Tokyo: Igaku-Shoin. pp. 176–186.
[30]
Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson TA, et al. (2013) A genome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population. Gastroenterology 144: 781–788. doi: 10.1053/j.gastro.2012.12.021. pmid:23266558
[31]
Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754–1760. doi: 10.1093/bioinformatics/btp324. pmid:19451168
[32]
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297–1303. doi: 10.1101/gr.107524.110. pmid:20644199
[33]
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491–498. doi: 10.1038/ng.806. pmid:21478889
[34]
Ng PC, Henikoff S (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812–3814. pmid:12824425 doi: 10.1093/nar/gkg509
[35]
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248–249. doi: 10.1038/nmeth0410-248. pmid:20354512
[36]
Choi Y, Sims GE, Murphy S, Miller JR, Chan AP (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One 7: e46688. doi: 10.1371/journal.pone.0046688. pmid:23056405
